- Scientific Scholar
Scientific Scholar is a publishing company established in 2016 with the aim of publishing scientific journals. Scientific Scholar's mission is Share, Learn and Improve. It is an advance manuscript management system developed by experienced journal editors/authors for the scientific publishing community.
(Filed: Mon Jul 17 2017)
- American Journal of Interventional Radiology
The American Journal of Interventional Radiology is an open access peer-reviewed International journal committed to publishing high-quality articles in the field of Interventional Radiology.
(Filed: Wed Jul 12 2017)
- Science Access
Science Access (SA) is initiated to meet a need or to pursue collective goals of the scientific community, especially in exchanging the ideas which facilitate growth of research and development. We specialize in organizing conferences, meetings and workshops on Nursing, Dental, Neurology, Nanotechnology, vaccines, and many more.
(Filed: Mon Jun 26 2017)
- Global Iron Ore Market ,Growth and Price Analysis and Forecast 2016
The high capital required for the iron ore industry is expected to pose challenges for the market growth during the forecast period. Huge investments are necessary for heavy machinery and infrastructure such as railways and harbors for the transport of iron ore from the mine to freight.
(Filed: Thu Jan 19 2017)
- Functional fluids Market to Grow at 4.41% CAGR to 2020
ReportsnReports.com adds Global Functional Fluids Market 2016-2020 latest research report, The analysts forecast global functional fluids market to grow at a CAGR of 4.41% during the period 2016-2020.
(Filed: Fri Aug 19 2016)
- Artificial Intelligence Around Us
Artificial Intelligence is already here, according to Artificial Intelligence Around Us (ISBN 978-1-58909-666-4), an intriguing and insightful new book just released by Bookstand Publishing.
(Filed: Sat Feb 06 2010)
- b3 bio inc. enters discovery collaboration with Roche
January, 2010. b3 bio inc. today announced that it has signed an agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) to source and develop innovative early stage technologies that could result in potential therapeutic benefits for patients.
(Filed: Fri Jan 22 2010)